Search results
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
GSK Gears Up to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report fourth-quarter 2022 results on Feb 1, before the opening bell. In the last...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 4 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
Why Is Glaxo (GSK) Up 6.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for GSK (GSK). Shares have added about 6.7% in...
AstraZeneca (AZN) Posts Upbeat Data on Lung Cancer Drug Combo
Zacks via Yahoo Finance· 8 months agoData from a late-stage study shows that AstraZeneca's (AZN) Tagrisso combined with chemotherapy cut...
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
Zacks via Yahoo Finance· 1 year agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive...
Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 28, 2022 – Today, Zacks Equity Research discusses...
GSK Clocks 10% Growth In Q1 Sales Excluding COVID-19 Products, Reaffirms Guidance
Benzinga via Yahoo Finance· 1 year agoGSK plc (NYSE: GSK) reported Q1 FY23 sales of £6.95 billion, down 3% Y/Y on the actual exchange rate...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 6 days agoGSK has announced positive data from two Phase III trials of its asthma candidate depemokimab. The pharma giant announced the drug met primary endpoints...
GSK strikes £1.1bn deal for asthma drugmaker
The Telegraph via Yahoo Finance· 5 months agoIt is hoped the treatment that's been purchased by GSK will help patients cut down on the use of inhalers - bymuratdeniz GSK has bought a drug to treat...
